| Product NDC: | 65224-545 |
| Proprietary Name: | Aldex CT |
| Non Proprietary Name: | PHENYLEPHRINE HYDROCHLORIDE and DIPHENHYDRAMINE HYDROCHLORIDE |
| Active Ingredient(s): | 12.5; 5 mg/1; mg/1 & nbsp; PHENYLEPHRINE HYDROCHLORIDE and DIPHENHYDRAMINE HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, CHEWABLE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65224-545 |
| Labeler Name: | Pernix Therapeutics, LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20100120 |
| Package NDC: | 65224-545-01 |
| Package Description: | 100 TABLET, CHEWABLE in 1 BOTTLE (65224-545-01) |
| NDC Code | 65224-545-01 |
| Proprietary Name | Aldex CT |
| Package Description | 100 TABLET, CHEWABLE in 1 BOTTLE (65224-545-01) |
| Product NDC | 65224-545 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | PHENYLEPHRINE HYDROCHLORIDE and DIPHENHYDRAMINE HYDROCHLORIDE |
| Dosage Form Name | TABLET, CHEWABLE |
| Route Name | ORAL |
| Start Marketing Date | 20100120 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Pernix Therapeutics, LLC |
| Substance Name | DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 12.5; 5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |